Related Experiment Video
Updated: Aug 7, 2026

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
CMT-type beta-lactamase TEM-125, an emerging problem for extended-spectrum beta-lactamase detection
Frédéric Robin1, Julien Delmas, Maryse Archambaud
1CHU Clermont-Ferrand, Laboratoire de Bactériologie, Faculté de Médecine, 63 001 Clermont-Ferrand, France. frobin@chu-clermontferrand.fr
A novel beta-lactamase, TEM-125, confers resistance to antibiotics like ceftazidime in Escherichia coli. This enzyme is difficult to detect using standard methods, highlighting potential risks for patient treatment.
Area of Science:
- Microbiology
- Biochemistry
- Molecular Biology
Background:
- Clinical isolates of Escherichia coli can exhibit resistance to common antibiotics.
- Extended-spectrum beta-lactamases (ESBLs) are a significant cause of antibiotic resistance.
- Standard detection methods may fail to identify certain novel beta-lactamases.
Purpose of the Study:
- To characterize a novel beta-lactamase, TEM-125, found in a clinical Escherichia coli strain.
- To investigate the resistance mechanisms conferred by TEM-125 against beta-lactam antibiotics and inhibitors.
- To assess the detectability of TEM-125 using current clinical laboratory standards.
Main Methods:
- Phenotypic characterization of Escherichia coli TO799 resistance to penicillin-clavulanate and ceftazidime.
- Enzymatic assays to determine hydrolytic activity against ceftazidime.
- Determination of inhibitory concentration against clavulanate.
- Comparison with CLSI and French Society for Microbiology guidelines for ESBL detection.
Main Results:
- Escherichia coli TO799 displayed resistance to penicillin-clavulanate and ceftazidime.
- A novel beta-lactamase, TEM-125, was identified as the cause of this resistance.
- TEM-125 demonstrated hydrolytic activity against ceftazidime and high resistance to clavulanate.
- TEM-125 was not reliably detected by standard ESBL screening methods.
Conclusions:
- TEM-125 represents a complex mutant TEM beta-lactamase with significant hydrolytic and resistance properties.
- The difficulty in detecting TEM-125 underscores the emergence of challenging ESBL variants.
- There is a critical need to update and evaluate diagnostic methods to ensure accurate ESBL detection and prevent therapeutic failures.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Development of Antibiotic Resistance
Rapid Identification of Pathogens
Microbial Biosensors

